FDA classifies device recall as serious due to potential for harm

Teleflex has recalled a percutaneous thrombolytic device kit due to reports that a component could detach from the device and embolize. The Food and Drug Administration has classified this as a Class 1 recall, the most serious type, due to the potential for serious adverse health consequences or death. The company said it has received seven complaints about the issue, but no reports of long-term patient complications. It advises health care providers to immediately stop using and return all affected product, and identify all patients currently exposed to it. Providers also may report adverse reactions or quality problems using the product to the FDA's MedWatch program.
Related News Articles
Headline
The AHA May 12 responded to the Office of Management and Budget's April 11 request for information on regulatory relief, making 100 suggestions to the Trump…
Headline
The U.S. has had 935 confirmed cases of measles so far this year, according to the latest data from the Centers for Disease Control and Prevention. Cases have…
Headline
The Food and Drug Administration published a notice from Amneal Pharmaceutical that said the company is recalling two lots of its Ropivacaine Hydrochloride…
Headline
The Food and Drug Administration has identified a Class I recall of Q’Apel Medical 072 Aspiration System after the company submitted three device event reports…
Headline
There have been 8,064 reported cases of whooping cough in the U.S. so far this year, according to the latest data from the Centers for Disease Control and…
Headline
A study published April 17 by BMC Infectious Diseases found increased incidents of Acinetobacter baumannii and carbapenem-resistant A. baumannii infections…